Hornet Therapeutics Revenue and Competitors

USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Hornet Therapeutics's estimated annual revenue is currently $775k per year.(i)
  • Hornet Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Hornet Therapeutics has 5 Employees.(i)
  • Hornet Therapeutics grew their employee count by 0% last year.

Hornet Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$9.1M59-9%N/AN/A
#10
$16.6M1073%N/AN/A
Add Company

What Is Hornet Therapeutics?

Hornet Therapeutics is a biotech company focused on developing treatments to address Epstein-Barr Virus (EBV) driven pathologies. The Company was founded by 4BIO Capital and Professor Christoph Hess, based on breakthrough work from Christoph Hess’s lab on translational aspects of lymphocyte function and its metabolic basis. Whilst in incubation, the Company established pioneering single gene-level precision engineering of immune cell metabolism to induce or abolish specific cellular states.

keywords:N/A

N/A

Total Funding

5

Number of Employees

$775k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M5-29%$36M
#2
$0.6M5-29%N/A
#3
$0.1M5-29%$12M
#4
$0.5M5-17%$76.7M
#5
$0.4M50%N/A